Mark N. Lampert, 10% Owner at LIGAND PHARMACEUTICALS INC (LGND), bought 16,591 shares at $14.99 ($252K) on 2012-10-31, disclosed to the SEC on 2012-11-02.
Open-market purchase of $252k LGND by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.26 | 12,515 | $191K | 75.8% |
| 2 | $14.99 | 4,076 | $61K | 24.2% |
| Total | $15.19 avg | 16,591 | $252K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |